On Monday, Edwards Lifesciences Corp (NYSE:EW)’s shares declined -5.32 % to $130.97.
Edwards Lifesciences Corp (EW) stated net income for the quarter ended March 31, 2015 of $123.4 million, or $1.12 per diluted share. Net income for the same period a year earlier was $60.3 million, or $0.56 per diluted share, and non-GAAP net income was $82.1 million, or $0.76 per diluted share.
Net sales for the quarter ended March 31, 2015 raised 13.0 percent to $590.3 million contrast to the same period last year. Underlying1 sales grew 21 percent. U.S. and international segment sales for the first quarter were $283.5 million and $306.8 million, respectively.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves.
Old National Bancorp (NASDAQ:ONB)’s shares dropped -5.61% to $13.46.
Old National Bancorp (ONB) stated 1st quarter 2015 net income of $20.9 million, or $.18 per share. These stated quarterly results compare to net income of $29.3 million in the 4th quarter of 2014 and $26.5 million recorded in the 1st quarter of 2014.
Impacting 1st quarter 2015 results were charges regarding several planned initiatives aimed at improving the long-term operating leverage of the Company. These 1st quarter pre-tax charges comprise $4.4 million in severance and $2.6 million regarding branch consolidations. Also comprised of in the current quarter were $4.0 million of pre-tax merger and integration expenses. Not taking into account the impact of these pre-tax charges, Old National would have stated net income of $28.5 million, or $.24 per share.
Old National Bancorp operates as the holding company for Old National Bank, which provides various financial services to individual and commercial customers in the United States.
At the end of Monday’s trade, Incyte Corporation (NASDAQ:INCY)‘s shares dipped -5.55% to $101.38.
Incyte Corporation (INCY) declared it will present at the following investor conferences during the month of May:
Deutsche Bank Securities 40th Annual Health Care Conference on Thursday, May 7, 2015 at 10:00 am (EDT) in Boston;
Bank of America Merrill Lynch 2015 Health Care Conference on Thursday, May 14, 2015 at 8:00 am (PDT) in Las Vegas; and
UBS Global Healthcare Conference on Tuesday, May 19, 2015 at 3:00 pm (EDT) in New York
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology.
Mallinckrodt PLC (NYSE:MNK), ended its Monday’s trading session with -5.46% loss, and closed at $115.35.
Mallinckrodt PLC (MNK) will present on Wednesday, May 6, 2015, at the Deutsche Bank 40th Annual Health Care Conference at the InterContinental Boston hotel in Boston, Mass.
Mark Trudeau, President and Chief Executive Officer; Matthew Harbaugh, Senior Vice President and Chief Financial Officer; and Cole Lannum, Senior Vice President of Investor Strategy and Investor Relations Officer, will represent the company in a session planned to start at 1:30 p.m. Eastern / 10:30 a.m. Pacific.
Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical products and medical imaging agents worldwide. The company operates through two segments, Specialty Pharmaceuticals and Global Medical Imaging.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
